Add to ORKGthe probability of relapse after discontinuation of migraine preventive treatment with topiramat
Immune checkpoint inhibitors (ICIs) have tremendously changed the therapeutic landscape of melanoma ...
Abstract Recurrence was first recognised as a clinical problem in 1989 with the advent of sumatripta...
L'autore è ricompreso nel TOPMAT-MIG-303 Investigators Group, il cui elenco è è riportato in calce a...
INTRODUCTION: Demographic and clinical variables were examined in a post hoc analysis of the PROlong...
Background Use of preventive therapy for migraine is often recommended for only 6-9 months, but no r...
To monitor weight regain after therapy discontinuation in patients with migraine experiencing weight...
Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse tients: ...
A substantial proportion of the burden of depression arises from its recurrent nature. The risk of r...
This journal suppl. entitled: Abstracts for the 12th International Congress on Schizophrenia Researc...
Topiramate, FDA approved for migraine prophylaxis, is a promising treatment in IIH because it can re...
The risk of relapse after antidepressant medication (ADM) discontinuation is high. Predictors of rel...
OBJECTIVES To determine the relapse rate after discontinuing treatment in patients with rheumatoid a...
Background: Medication overuse headache (MOH) is the third most prevalent headache type after migrai...
<p>Odds ratios higher than 1 reflect a higher discontinuation rate due to adverse events in the subs...
BACKGROUND & AIMS: It is important to determine whether infliximab therapy can be safely interrupted...
Immune checkpoint inhibitors (ICIs) have tremendously changed the therapeutic landscape of melanoma ...
Abstract Recurrence was first recognised as a clinical problem in 1989 with the advent of sumatripta...
L'autore è ricompreso nel TOPMAT-MIG-303 Investigators Group, il cui elenco è è riportato in calce a...
INTRODUCTION: Demographic and clinical variables were examined in a post hoc analysis of the PROlong...
Background Use of preventive therapy for migraine is often recommended for only 6-9 months, but no r...
To monitor weight regain after therapy discontinuation in patients with migraine experiencing weight...
Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse tients: ...
A substantial proportion of the burden of depression arises from its recurrent nature. The risk of r...
This journal suppl. entitled: Abstracts for the 12th International Congress on Schizophrenia Researc...
Topiramate, FDA approved for migraine prophylaxis, is a promising treatment in IIH because it can re...
The risk of relapse after antidepressant medication (ADM) discontinuation is high. Predictors of rel...
OBJECTIVES To determine the relapse rate after discontinuing treatment in patients with rheumatoid a...
Background: Medication overuse headache (MOH) is the third most prevalent headache type after migrai...
<p>Odds ratios higher than 1 reflect a higher discontinuation rate due to adverse events in the subs...
BACKGROUND & AIMS: It is important to determine whether infliximab therapy can be safely interrupted...
Immune checkpoint inhibitors (ICIs) have tremendously changed the therapeutic landscape of melanoma ...
Abstract Recurrence was first recognised as a clinical problem in 1989 with the advent of sumatripta...
L'autore è ricompreso nel TOPMAT-MIG-303 Investigators Group, il cui elenco è è riportato in calce a...